Sale!

Immunohistochemistry INI-1 Test Cost

Original price was: 550 د.إ.Current price is: 500 د.إ.

-9%

The Immunohistochemistry INI-1 test is a specialized diagnostic procedure performed at DNA Labs UAE, designed to detect the presence of the INI-1 protein in tissue samples. This test is particularly important in the diagnosis of certain tumors, including atypical teratoid/rhabdoid tumors (AT/RT) and other malignancies where INI-1 protein loss is a key feature. The INI-1 gene, also known as SMARCB1, plays a crucial role in tumor suppression, and its absence can be indicative of specific cancer types.

During the test, a tissue sample is treated with antibodies that react specifically with the INI-1 protein. The presence or absence of this protein is then visualized under a microscope, providing valuable information for diagnosis and treatment planning. The cost of the Immunohistochemistry INI-1 test at DNA Labs UAE is set at 500 AED, making it an accessible option for patients seeking advanced diagnostic services in the region. By offering this test, DNA Labs UAE contributes significantly to the accurate diagnosis and management of complex cancers, enhancing patient care outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY INI-1 Test

Components: INI-1 Test

Price: 500.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days

Method: Immunohistochemistry

Test type: Cancer

Doctor: Oncologist, Pathologist

Test Department: Pre Test Information

Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details

The INI-1 (Integrase Interactor 1) immunohistochemistry test is a diagnostic tool used to detect the loss of INI-1 protein expression in tumor cells. INI-1 is a tumor suppressor protein that plays a crucial role in regulating cell growth and division.

Loss of INI-1 expression is most commonly associated with a rare type of pediatric kidney cancer called malignant rhabdoid tumor (MRT). However, loss of INI-1 expression has also been observed in other tumor types, including epithelioid sarcoma and some cases of atypical teratoid/rhabdoid tumor (AT/RT).

The INI-1 immunohistochemistry test involves staining tissue sections with an antibody specific to INI-1 protein. If INI-1 protein is present in the tumor cells, it will be visualized as brown staining within the cell nucleus. Loss of INI-1 expression is indicated by the absence of nuclear staining in tumor cells.

The INI-1 immunohistochemistry test is an important tool in the diagnosis of MRT and other INI-1-deficient tumors. It can help differentiate these tumors from other malignancies that may have similar histological features. Additionally, the test can aid in identifying patients who may benefit from targeted therapies or clinical trials specifically designed for INI-1-deficient tumors.

Test Name IMMUNOHISTOCHEMISTRY INI-1 Test
Components
Price 500.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department:
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The INI-1 (Integrase Interactor 1) immunohistochemistry test is a diagnostic tool used to detect the loss of INI-1 protein expression in tumor cells. INI-1 is a tumor suppressor protein that plays a crucial role in regulating cell growth and division.

Loss of INI-1 expression is most commonly associated with a rare type of pediatric kidney cancer called malignant rhabdoid tumor (MRT). However, loss of INI-1 expression has also been observed in other tumor types, including epithelioid sarcoma and some cases of atypical teratoid/rhabdoid tumor (AT/RT).

The INI-1 immunohistochemistry test involves staining tissue sections with an antibody specific to INI-1 protein. If INI-1 protein is present in the tumor cells, it will be visualized as brown staining within the cell nucleus. Loss of INI-1 expression is indicated by the absence of nuclear staining in tumor cells.

The INI-1 immunohistochemistry test is an important tool in the diagnosis of MRT and other INI-1-deficient tumors. It can help differentiate these tumors from other malignancies that may have similar histological features. Additionally, the test can aid in identifying patients who may benefit from targeted therapies or clinical trials specifically designed for INI-1-deficient tumors.